Ferrostatin-1 (Fer-1), an ferroptosis inhibitor, reduces the effects of pro-inflammatory cytokines interleukin (IL)-6 and tumor necrosis factor (TNF-α) in bronchoalveolar lavage fluid have a therapeutic effect on LPS-induced ALI (Liu et al., 2020). Here, TNF is linked to acute respiratory distress syndrome.